Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East

Fig. 3

Impact of various factors identified on multivariate analysis and HL- International Prognostic Score on EFS. a EFS of stage III-IV with 0, 1, 2 risk factors. b EFS and HL- International Prognostic Score. c EFS of stage I-II according to the German Hodgkin Study Group risk models; early favorable and early unfavorable

Back to article page
\